Language selection

Government of Canada / Gouvernement du Canada

Search

We have archived this page and will not be updating it.

You can use it for research or reference. For the latest data updated on a weekly basis, please see the current weekly report .

COVID-19 epidemiology update Download page in .pdf format

Summary of COVID-19 cases, hospitalizations and deaths, testing and variants of concern across Canada and over time.

Current update Archived reports

Current update

Updated:

This summary of COVID-19 cases across Canada contains detailed data about the spread of the virus over time and in different regions of the country. Includes breakdowns by age and sex or gender. Provides an overview of testing, variants of concern, cases following vaccination and severe illness and outcomes.

Update schedule : We update all sections of this page every Friday, except for 'Cases following vaccination', which we update on Tuesdays.

Changes to update schedule

On June 10, 2022, we changed this page to reflect current reporting by the provinces and territories. We’ve switched from daily to weekly updates for cases, deaths and laboratory tests in the following sections: Key updates, Current situation and National overview.

On this page

Key COVID-19 updates (Last data update )

Notes
Key COVID-19 updates: Text description
Key COVID-19 updates (Last data update )
Weekly change in cases {Weekly cases}
Total cases {Total cases}
Weekly change in deaths {Weekly deaths}
Total deaths {Total deaths}
Total tests performed {Tests performed today}
Daily percent positive (last 7 days) {Daily percent positive (last 7 days)} %
Daily tests per 100,000 population (last 7 days) {Rate tests}

Current situation

Figure 1a. of of COVID-19, (Last data update )

Hover over or tap regions to see cases , and deaths and tests performed in Canada over time. Click the play button to animate the map. Map data is available in .csv and .json formats and data dictionaries for cases and deaths .csv and for lab indicators .csv .

The count of total cases in Canada was 1,471 .

Download data in .csv format
Notes

Figure 1a: Text description
Areas in Canada with cases of COVID-19
Location Total cases Cases (latest week) Cases (latest 2 weeks) Total deaths Deaths (latest week) Deaths (latest 2 weeks) Total tests performed Moving average daily tests performed (latest week) Moving average daily percent positivity (latest week)
Count Rate * Count Rate * Count Rate * Count Rate * Count Rate * Count Rate * Count Count Rate * Percent
  1. * Rate per 100,000 population
  2. Out of the total number of people tested, 76 were repatriated travellers, of which 13 were cases.
Health regions in Canada with cases of COVID-19
Province Health Region Total cases Cases last 14 days Total deaths Deaths last 14 days
Count Rate * Count Rate * Count Rate * Count Rate *

‡ No data is available for this day, and so the most recently available data is displayed.

† Rate per 1,000,000 population

* Rate per 100,000 population

Note: Out of the total number of people tested, 76 were repatriated travellers, of which 13 were cases.

Figure 1b. of of COVID-19 in Canada (Last data update )

The figures below show cases over time. The range of dates (January 31st, 2020 - present date) is the same for each figure. This allows you to compare the provinces and territories on the same timescale.

Notes
Figure 1b: Text description
  1. Downloadable data (in .csv format) .
  2. Due to changes in COVID-19 testing policies in many jurisdictions starting in late December 2021, case counts will under estimate the total burden of disease.
  3. Out of the total number of people tested, 76 were repatriated travellers, of which 13 were cases.
  4. As of April 11, 2022, Nunavut no longer publishes regular COVID-19 updates.
  5. Starting April 7, 2022, British Columbia reports all deaths within 30 days of a positive COVID-19 test, regardless of the cause of death. As a result, deaths are now over-estimated for BC and should not be directly compared to other jurisdictions or to earlier data from BC.

National overview

There have been (Num tests} COVID-19 tests performed in Canada or 1,620,777 tests per 1 million people .

Table 1. Weekly* change in the number of cases, deaths and tests performed, by province or territory, (Last data update )
Location Cases Deaths Tests performed
Notes
  1. * Weekly change in cases, deaths and tests performed reflect the changes in the case and death counts between the end of the latest week and the end of the previous week. Data are updated on an ongoing basis. The current report reflects data most recently received by PHAC at the time of the last update and are subject to change.
  2. N/A means that no update was provided by the province or territory for the latest week.
  3. Due to changes in COVID-19 testing policies in many jurisdictions since December 2021, case counts are under-estimated.
  4. Starting April 7, 2022, British Columbia reports all deaths within 30 days of a positive COVID-19 test, regardless of the cause of death. As a result, deaths are now over-estimated for BC and should not be directly compared to other jurisdictions or to earlier data from BC.

COVID-19 variants in Canada

All viruses, including COVID-19, change over time. These changes are called mutations, and result in variants of the virus. Not all mutations are of concern. Most do not cause more severe illness. However, some mutations result in variants of concern or variants of interest.

A variant of concern has mutations that are significant to public health. Before a variant of interest is considered one of concern, scientists and public health professionals must determine if the mutations result in an actual change in the behaviour of the virus. For example, it might:

There are several variants of interest that have mutations similar to variants of concern, but we don’t yet know if they pose a higher risk to public health.

The Public Health Agency of Canada (PHAC) works with provincial and territorial partners and the Canadian COVID-19 Genomics Network (CanCOGeN) to sequence a percentage of all positive COVID-19 test results. Sequencing reveals the genetic code of the virus, which tells us which variant is involved in a specific case of COVID-19. We report the proportion of COVID-19 variants in Canada every week.

We collect evidence to determine if new variants meet the definition for a variant of concern or a variant of interest . Many variants are being tracked across Canada and around the world. Variants of concern now represent a majority of COVID-19 cases in Canada.

Current variants of concern in Canada include:

New variants will continue to appear. We must remain vigilant and take all available measures to limit spread.

Figure 2. Weekly variant breakdown Updated: December 31, 2021 , 4 pm EDT download weekly variant breakdown data in .csv format

The graphic shows the percentage mix of COVID-19 variants detected in Canada through whole genome sequencing, by week of sample collection. You can see the numbers for each date by hovering over, tabbing to, or long-pressing any of the bars. To see a specific variant or variant grouping, click or press return. Repeat to restore the complete graph. Sublineages or offshoots for some variants can be revealed or hidden by clicking on the name of the variant in the legend.

This information is based on whole genome sequencing from surveillance testing in all provinces and territories. In addition to sequencing done by the National Microbiology Laboratory in Winnipeg, data is included from provincial and territorial laboratories .

Sequencing takes from 1 to 3 weeks to complete, so the proportions for recent weeks may change as more data are added. Surveillance in each province or territory is organized and prioritized according to local needs and may change from time to time. Because of differences in local sampling and reporting, the percentages illustrate trends rather than precise measurements.

Weekly variant breakdown

Percentage of COVID-19 cases identified through whole genome sequencing, presented by variant and by week of sample collection.

Figure 2: Text description
Variant Grouping

Note : The shaded columns on the right represent a period of accumulating data.

Contributing laboratories:

  • National Microbiology Laboratory (NML) - supplemental sequencing for all provinces and territories

Detailed case information

The tables and figures below reflect detailed case information provided to the Public Health Agency of Canada (PHAC) by health authorities in the provinces and territories. This data is updated every week. It may change as we get more information about cases.

Updated: June 25, 2021, 9 am EST

Epidemic curve

As of June 25, 2021, 9 am EST , PHAC has received detailed case report data on cases.

The shaded area on the far right of Figure 3 represents a period of accumulating data. This is the period of time (1 to 2 weeks) before the latest cases are reported to PHAC. This delay is a result of the time required to seek health care, get tested and receive results. It also takes time for public health authorities to gather information on cases. We update this information as it becomes available.

Figure 3. COVID-19 cases (n= Footnote 1 ) in Canada by date Footnote 2 as of ( )

Figure 3. COVID-19 cases (n= Footnote 1 ) in Canada by date Footnote 2 as of (total cases)

Figure 3. COVID-19 cases (n= Footnote 1 ) in Canada by date Footnote 2 as of (by age - 10 year groups)

Figure 3. COVID-19 cases (n= Footnote 1 ) in Canada by date Footnote 2 as of (by age - 20 year groups)

Figure 3: Text description
COVID-19 cases (n= Footnote 1 *) in Canada by date Footnote 2 as of
Date Footnote 2 0-11 12-19 20-29 30-39 40-49 50-59 60-69 70-79 80+
COVID-19 cases (n= Footnote 1 *) in Canada by date Footnote 2 as of
Date Footnote 2 0-19 20-39 40-59 60-79 80+

Demographics

We have detailed case report data from 99,853 cases. We know the age of patients in 99.78 % of cases, and both age and gender in 99.98 % of cases.

Of the cases reported in Canada so far, {Percent Gender} were {Gender} and {Percent of Over 60} were between 20 and 39 years old (Figure 4).

Figure 4.

Figure 4: Text description
Age by gender Footnote 3 distribution of COVID-19 cases (n= Footnote 1 ) in Canada,
Age group (years) Number of cases with case reports (percentage) Number of male cases (percentage) Number of female cases (percentage) Number of other cases (percentage)

Cases following vaccination

Data extracted on for cases from December 14, 2020 up until .

Changes to update schedule

We’re adjusting our update schedule to reflect recent changes in how often this data is reported to us.

While the COVID-19 vaccines are highly effective at preventing severe outcomes, a percentage of the population who are vaccinated may become infected with COVID-19 if they are exposed to the virus that causes it. This means that even with high vaccine effectiveness, a percentage of people who are vaccinated against COVID-19 will still get sick and some may be hospitalized or die.

It is also possible that a person could be infected just before or just after vaccination and still get sick. It typically takes about two weeks for the body to build protection after vaccination, so a person could get sick if the vaccine has not had enough time to provide protection.

As the majority of Canadians are now vaccinated, counts will inherently be higher within this population, compared to the unvaccinated population. However, risk among this population may be lower, despite higher case counts.

Due to the rapid increase in cases starting December 2021, delays in data entry, and changes in COVID-19 testing policies in many jurisdictions, case counts will under estimate the total burden of disease, and may over-represent people at risk of severe disease. Data should be interpreted with caution.

Cases reported since the start of the vaccination campaign, as of July 03, 2021

Since the start of the vaccination campaign on December 14, 2020, PHAC received case-level vaccine history data for 75.5 % (n= 624,980 ) of COVID-19 cases aged 5 years or older.

Of these cases:

Figure 5. of confirmed COVID-19 cases reported to PHAC by vaccination status as of July 10, 2021

Figure 5: Text description
Characteristics and severe outcomes associated unvaccinated, partially vaccinated and fully vaccinated confirmed cases reported to PHAC, as of July 10, 2021
Status Cases Hospitalizations Deaths

July 10, 2021 .

Of these people:

Based on detailed case information reported to PHAC from provinces and territories, cases following vaccination were reported more frequently among females (Table 2). This may be the result of higher vaccination coverage in Canada among females due to the prioritization of healthcare workers as part of the vaccine rollout.

Table 2. Characteristics and severe outcomes among unvaccinated, partially vaccinated, fully vaccinated, and fully vaccinated with additional dose confirmed cases reported to PHAC, as of July 10, 2021

Individuals fully vaccinated and fully vaccinated with an additional dose who were diagnosed with COVID-19 were significantly protected from severe outcomes. From January 30, 2022 to February 27, 2022 , compared to fully vaccinated cases, unvaccinated cases were XX times more likely to be hospitalized and XX times more likely to die as a result of their illness. Compared to cases fully vaccinated with an additional dose, unvaccinated cases were XX times more likely to be hospitalized and XX times more likely to die as a result of their illness, during this same 4-week period (Table 3).

Table 3. Risk of severe outcomes among unvaccinated cases, compared to fully vaccinated cases and cases fully vaccinated with an additional dose, January 30, 2022 to February 27, 2022
Table 3. Risk of severe outcomes among unvaccinated cases, compared to fully vaccinated cases and cases fully vaccinated with an additional dose, January 30, 2022 to February 27, 2022
Severe Outcome 4-week age standardized* rate ratio, unvaccinated compared to fully vaccinated 4-week age standardized* rate ratio, unvaccinated compared to fully vaccinated with an additional dose

  • *Age-standardized using July 2021 Canadian population estimates
  • Source: Detailed case information received by PHAC from provinces and territories
  • Note :
    • Rate ratio calculations were based on data from nine provinces and territories that have reported complete case-level vaccine history data to PHAC during the 4-week period of analysis.

Definitions

Data for this analysis is extracted from the COVID-19 national data set, which contains detailed case-level information received by PHAC from all provinces and territories. Note that a data cut-off of was used to account for any reporting delays associated with vaccine history information. There are currently twelve jurisdictions reporting case-level vaccine history data to PHAC as part of the national COVID-19 dataset.

PHAC monitors cases following vaccination using the following categories:

  • Unvaccinated cases : include those who were unvaccinated at the time of their episode date.
  • Cases not yet protected from vaccination include those whose episode date occurred less than 14 days after their first dose of the vaccine.
  • Partially vaccinated cases include those whose episode date occurred 14 days or more after their first vaccine dose or less than 14 days after their second dose of the vaccine.
  • Fully vaccinated cases include those whose episode date occurred 14 days or more after receipt of a second dose in a two-dose series or 14 days or more after receipt of one dose of a one-dose vaccine series,, and, if an additional (i.e., third or booster) dose was received, 0 to <14 days after receipt of the additional dose.
  • Fully vaccinated cases with an additional dose include those whose episode date occurred 14 days or more following the receipt of at least one additional dose (e.g., third or booster) of a COVID-19 vaccine product, after being fully vaccinated.

Note : A COVID-19 vaccine product includes vaccines authorized by Health Canada and vaccines accepted by the Government of Canada for the purpose of travel to and within Canada .

When symptom onset date is unavailable or the case is asymptomatic, episode date uses the following dates as a proxy for classification: laboratory specimen collection date, or laboratory testing date.

For more information on cases following vaccination, please see the Weekly epidemiology report (PDF) available on the Government of Canada’s COVID-19 data trends page.

Severe illness and outcomes

Hospital use

Figure 6. Daily number of hospital beds and ICU beds occupied by COVID-19 patients as of

Download hospitalization, ICU and mechnical ventilation data in .csv format
Figure 6: Text description
Daily Census of COVID-19 Patients who were hospitalized, vented or in the ICU as of
Date Total patients hospitalized Patients hospitalized in non-ICU Patients in the ICU Patients who were mechanically vented

Between October 10 and Oct 17 :

Hospitalizations and deaths to date

We have detailed case report data on 99,853 cases, and hospitalization status for 65,597 ( xx %) of them:

The provinces and territories provided detailed case report forms for {Num Deaths} deaths related to COVID-19.

Figure 7. Age and gender Footnote 3 distribution of COVID-19 cases in Canada as of (n= Footnote 1 )

Figure 7a. Age and gender Footnote 3 distribution of COVID-19 cases hospitalized in Canada as of (n= Footnote 1 )

Figure 7b. Age and gender Footnote 3 distribution of COVID-19 cases admitted to ICU in Canada as of (n= Footnote 1 )

Figure 7c. Age and gender Footnote 3 distribution of COVID-19 cases deceased in Canada as of (n= Footnote 1 )

Data note: Figure 7 includes COVID-19 cases hospitalized, admitted to ICU, and deceased for which age and gender information were available. Therefore, some COVID-19 hospitalizations, ICU admissions, and deaths may not be included in Figure 7.

Figure 7: Text description
Age and gender Footnote 4 distribution of COVID-19 cases hospitalized in Canada as of (n= Footnote 1 )
Age group (years) Number of cases with case reports (percentage) Number of male cases (percentage) Number of female cases (percentage) Number of other cases (percentage)
Age and gender Footnote 4 distribution of COVID-19 cases admitted to ICU in Canada as of (n= Footnote 1 )
Age group (years) Number of cases with case reports (percentage) Number of male cases (percentage) Number of female cases (percentage) Number of other cases (percentage)
Age and gender Footnote 4 distribution of COVID-19 cases deceased in Canada as of (n= Footnote 1 )
Age group (years) Number of cases with case reports (percentage) Number of male cases (percentage) Number of female cases (percentage) Number of other cases (percentage)

Provincial, territorial and international reporting

For more information, please refer to provincial or territorial COVID-19 webpages:

Additional COVID-19 data resources

Download cases and deaths data (.csv) and lab indicators data (.csv)

Download cases and deaths data dictionary (.csv) and lab indicators data dictionary (.csv)

Download report (.pdf)

To learn more, visit COVID-19 data trends

Report a problem or mistake on this page
Date modified: